Sodium polystyrene sulfonate dosing guidelines for the treatment of adult hyperkalemia

Hospital Pharmacy

Volumn 39, Issue 8, 2004, Pages 765-771

  Mikrut, Michael ^a   Brockmiller Sell, Heather ^a  

^a MERCY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Hyperkalemia; Sodium polystyrene sulfonate

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSTYRENESULFONATE SODIUM; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

ADULT; AGED; CLINICAL ARTICLE; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPERKALEMIA; MALE; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; SUSPENSION; TREATMENT OUTCOME;

EID: 4043139454     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870403900808     Document Type: Review

References (11)

1. Perazella MA. Drug-induced hyperkalemia: Old culprits and new offenders. Am J Med. 2000;109:307-14.
2. Perazella MA, Mahnensmith RL. Hyperkalemia in the elderly: Drugs exacerbate impaired potassium homeostasis, a clinical review. J Gen Intern Med. 1997;12:646-56.
3. Shepkens H, Vanholder R, Billiouw JM, et al. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of twenty-five cases. Am J Med. 2001; 110:438-41.
4. Acker CG, Johnson JP, Palevsky PM, et al. Hyperkalemia in hospitalized patients. Arch Intern Med. 1998; 158:917-24.
5. Chew M, Bult J, Schiff G. Drug-induced hyperkalemia. Hosp Pharm. 2001;36(6):684-7.
6. Jeha S. Tumor lysis syndrome. Semin Hematol. 2001;38(4 suppl 10):4-8.
7. Sauret JM, Marindes G, Wang GK. Rhadbomyolysis. Am Fam Physician. 2002;65(5):907-12.
8. Garth D. Hyperkalemia. eMedicine [online journal]. 2001;2(7). Section 2. http://www.emedicine.com. Accessed November 12, 2001.
9. Singer GG. The Washington Manual of Medical Therapeutics: Fluid and Electrolyte Management. 29th ed. Lippincott, Williams and Wilkins; 1998.
10. Kayexalate (sodium polystyrene sulfonate cation-exchange resin) powder. Sanofi-Synthelabo. Physician's Desk Reference. http://www.healthandage.com. Accessed October 25, 2001.
11. Dipiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 4th ed. Appleton & Lange; 1999.